Back to Blog

Kristen Fortney, CEO of BioAge Labs, on AI for Aging Research

Simon Smith

On this episode of the Artificial Intelligence in Drug Discovery podcast, I speak with Kristen Fortney, founder and CEO of BioAge Labs. Kristen leads one of just a few companies focused explicitly on aging itself, rather than the diseases for which aging puts people at greater risk.

Listen now to learn how BioAge combines unique data sources with in silico analysis and lab experimentation to expedite the search for novel interventions that might just help you live healthier, longer:

Topics: Artificial Intelligence in Drug Discovery

Written by
Simon Smith

Never Miss a Blog Post!